Zhongyianke Biotech Stock

Zhongyianke Biotech is a biotechnology firm.

Sign up today and learn more about Zhongyianke Biotech Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Zhongyianke Biotech Stock

Zhongyianke has launched a flu vaccine and is conducting clinical trials on four other human vaccines: a tetravalent influenza vaccine, a tetravalent meningococcal vaccine, a rabies vaccine, and a rubella vaccine. The company holds 14 China patents. In addition to its operations in Tianjin, the company has an R&D center in Beijing and a production facility in Liaoning Province.

Funding History

July 2019$36.0M

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: